Aid agencies must invest more in strengthening health systems and infrastructure to avoid many millions of people losing their lives to multidrug-resistant tuberculosis by 2050, a group of U.K. members of Parliament said on World Tuberculosis Day.
Their call to action is backed by senior figures in the pharmaceutical sector, who told Devex preventing a resurgent TB pandemic was not only dependent on drug development.
Research published this week by the U.K. All Party Parliamentary Group on Global TB claims 75 million people could lose their lives to MDR-TB over the next 35 years and cost the global economy $16.7 trillion.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).